These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17631225)

  • 21. Keeping our eyes on the prize: low density lipoprotein cholesterol.
    de Lemos JA; Khera A
    Am J Cardiol; 2009 Dec; 104(12):1697-8. PubMed ID: 19962478
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.
    Frolkis JP; Pearce GL; Sprecher DL
    Am J Cardiol; 2004 Nov; 94(10):1310-2. PubMed ID: 15541255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of evidence for recommended low-density lipoprotein cholesterol treatment targets.
    Ravnskov U
    Ann Intern Med; 2007 Apr; 146(8):614; author reply 614-5. PubMed ID: 17438325
    [No Abstract]   [Full Text] [Related]  

  • 25. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
    Nishimura R; Sone H; Nakagami T; Tajima N
    Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical treatment of aortic stenosis: promising, or wishful thinking?
    Pearlman AS
    J Am Coll Cardiol; 2002 Nov; 40(10):1731-4. PubMed ID: 12446054
    [No Abstract]   [Full Text] [Related]  

  • 27. Aortic sclerosis, aortic stenosis and lipid-lowering therapy.
    Rosenhek R; Baumgartner H
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):385-90. PubMed ID: 18327997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapies for raising high-density lipoprotein cholesterol.
    Miura S; Saku K
    Intern Med; 2007; 46(7):339-40. PubMed ID: 17409593
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 30. Ask the doctor. I have been taking a statin to bring down my LDL cholesterol, but my HDL is still on the low side. Do I need to worry about my HDL level if my LDL is okay? If so, what should I do?
    Bhatt DL
    Harv Heart Lett; 2014 May; 24(9):2. PubMed ID: 25151665
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pleiotropic effects of statins].
    Palomäki A
    Duodecim; 2004; 120(4):411-8. PubMed ID: 15065459
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.
    Bellamy MF; Pellikka PA; Klarich KW; Tajik AJ; Enriquez-Sarano M
    J Am Coll Cardiol; 2002 Nov; 40(10):1723-30. PubMed ID: 12446053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins.
    Gadarla M; Kearns AK; Thompson PD
    Am J Cardiol; 2008 Jun; 101(12):1747-8. PubMed ID: 18549851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 38. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
    Klose G
    MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 40. Aggressive lipid reduction provides additional clinical benefit.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():1, 4. PubMed ID: 12608148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.